Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias

被引:12
|
作者
Kaplan, AA [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Div Nephrol, Dept Med, Farmington, CT 06030 USA
来源
THERAPEUTIC APHERESIS | 2001年 / 5卷 / 03期
关键词
multiple myeloma; mixed cryoglobinemia; membranoproliferative glomerulonephritis; macroglobulinemia; therapeutic plasma exchange;
D O I
10.1046/j.1526-0968.2001.00301.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disordered immunoglobulin synthesis can result in a variety of different types of renal pathology. Multiple myeloma is often associated with the overproduction of light chains which may result in toxicity to the renal tubules and acute renal failure. Patients with mixed cryoglobulinemia will have renal involvement which is most often in the form of a membranoproliferative glomerulonephritis. Renal involvement in macroglobulinemia is relatively uncommon, but IgM thrombi can be so voluminous as to occlude the glomerular capillary lumen. In each of these examples, therapeutic plasma exchange has been found to be a useful adjunct to the eventual chemotherapy required for the definitive treatment of these disorders.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [31] Current therapeutic uses of lenalidomide in multiple myeloma
    Hideshima, T
    Richardson, PG
    Anderson, KC
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (02) : 171 - 179
  • [32] Initial Therapeutic Approaches to Patients with Multiple Myeloma
    Hadi E. Berbari
    Shaji K. Kumar
    Advances in Therapy, 2021, 38 : 3694 - 3711
  • [33] The kinase NIK as a therapeutic target in multiple myeloma
    Gardam, Sandra
    Beyaert, Rudi
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (02) : 207 - 218
  • [34] Advances in the biology and therapeutic management of multiple myeloma
    Kaufmann H.
    Urbauer E.
    Ackermann J.
    Huber H.
    Drach J.
    Annals of Hematology, 2001, 80 (8) : 445 - 451
  • [35] Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
    Weiser Drozdkova, Denisa
    Smesny Trtkova, Katerina
    CURRENT ONCOLOGY, 2021, 28 (03) : 2087 - 2096
  • [36] MULTIPLE-MYELOMA - CURRENT THERAPEUTIC APPROACHES
    TROUSSARD, X
    BAUDUER, F
    LEPORRIER, M
    BULLETIN DU CANCER, 1992, 79 (03) : 231 - 242
  • [37] Therapeutic progress in relapsed/refractory multiple myeloma
    Chen, Qi
    Zhang, Min
    Zheng, Shan
    Tong, Yuxin
    Tan, Yamin
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 1833 - 1841
  • [38] Immunomodulation as a therapeutic strategy in the treatment of multiple myeloma
    Mitsiades, Constantine S.
    Chen-Kiang, Selina
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 : S5 - S13
  • [39] CircRNAs: novel therapeutic targets in multiple myeloma
    Zhou, Xinyi
    Du, Juan
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (11) : 10667 - 10676
  • [40] Initial Therapeutic Approaches to Patients with Multiple Myeloma
    Berbari, Hadi E.
    Kumar, Shaji K.
    ADVANCES IN THERAPY, 2021, 38 (07) : 3694 - 3711